Christopher Stevens
Vermogen: 2 M $ op 30-06-2026
Vermogen: 2 M $ op 30-06-2026
Christopher Stevens is Chief Operating Officer at Rocket Pharmaceuticals, Inc. since 2025.
Formerly, Mr. Stevens was Chief Patent Supply Officer & Executive VP at Spark Therapeutics, Inc. from 2022 to 2025.
Education includes undergraduate studies at Purdue University and graduate studies at the University of Southern Indiana.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 11-02-2026 | 469.129 ( 0,43% ) | 2 M $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | Operationeel Directeur | 07-07-2025 |
| Bedrijven | Functie | Einde |
|---|---|---|
| SPARK THERAPEUTICS, INC. | Corporate Officer/Principal | 01-07-2025 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Purdue University
Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Southern Indiana
University of Southern Indiana Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spark Therapeutics, Inc.
Spark Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy products for debilitating diseases | Health Technology |
Rocket Pharmaceuticals, Inc.
Rocket Pharmaceuticals, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau